US NOVARTIS PHARMACEUTICALS
2025–2026 federal contribution records · FEC Schedule A
01
Contribution summary
Loading the financial summary…
Reading the shared contribution publication for this cycle.
2025–2026 federal contribution records · FEC Schedule A
Loading the financial summary…
Reading the shared contribution publication for this cycle.
Federal contribution records grouped across normalized variants of this reported employer. Contributions are made by individuals, not by the employer.
Current-version rows · memo entries excluded from net amount
Last updated .
Loading 10 contributions with dates…
Loading company overview…
These immutable labels appeared in FEC filings and are grouped under US NOVARTIS PHARMACEUTICALS.
Top 10 contributors and top 10 recipients · independent of list pagination
Explore the reported connections for Novartis Pharmaceuticals Corporation. Contributor and recipient lists are available below.
Data: GovMoneyGraph, based on FEC records. Groupings and recipient-party allocations are derived analysis, not FEC-verified identities or party registrations. Read our contribution and classification methodology.
Reported contributor groups, with evidence-based name-variant matching; not verified unique people · 10 per page
Showing 1–10 of 175 · largest absolute amount first
Reported name + ZIP cluster; not a verified identity merge · EAST HANOVER, NJ, 07936 · US NOVARTIS PHARMACEUTICALS · Healthcare & Pharmaceuticals · PRESIDENT INNOVATIVE MEDICINES US · 2 transaction rows
Other contributionsDerived from contributionsReported name + ZIP cluster; not a verified identity merge · EAST HANOVER, NJ, 07936 · US NOVARTIS PHARMACEUTICALS · Healthcare & Pharmaceuticals · CHIEF MKT & CUSTOMER EXP OFFICER US · 37 transaction rows
Other contributionsDerived from contributionsReported name + ZIP cluster; not a verified identity merge · EAST HANOVER, NJ, 07936 · US NOVARTIS PHARMACEUTICALS · Healthcare & Pharmaceuticals · EVP CHIEF COMMERCIAL OFFICER US · 37 transaction rows
Other contributionsDerived from contributionsReported name + ZIP cluster; not a verified identity merge · EAST HANOVER, NJ, 07936 · US NOVARTIS PHARMACEUTICALS · Healthcare & Pharmaceuticals · US COUNTRY HEAD OF PEOPLE & ORGANIZATI · 37 transaction rows
Other contributionsDerived from contributionsReported name + ZIP cluster; not a verified identity merge · EAST HANOVER, NJ, 07936 · US NOVARTIS PHARMACEUTICALS · Healthcare & Pharmaceuticals · CHIEF INSIGHTS AND DECISION SCI. OFFIC · 37 transaction rows
Other contributionsDerived from contributionsEvidence-based cluster of 2 reported identities; not a verified identity merge · EAST HANOVER, NJ, 07936 · US NOVARTIS PHARMACEUTICALS · Healthcare & Pharmaceuticals · VP LEGAL HEAD INTEGRATED MARKETING ORG · Reported as WATSON, MONICA / WATSON, MONICA N · 37 transaction rows
Other contributionsDerived from contributionsReported name + ZIP cluster; not a verified identity merge · EAST HANOVER, NJ, 07936 · US NOVARTIS PHARMACEUTICALS · Healthcare & Pharmaceuticals · CHIEF CUSTOMER ENGAGEMENT OFFICER US · 30 transaction rows
Other contributionsDerived from contributionsReported name + ZIP cluster; not a verified identity merge · NEW YORK, NY, 10020 · US NOVARTIS PHARMACEUTICALS · Healthcare & Pharmaceuticals · CHIEF PATIENT EXPERIENCE OFFICER · 1 transaction rows
Other contributionsDerived from contributionsEvidence-based cluster of 2 reported identities; not a verified identity merge · CAMBRIDGE, MA, 02139 · NOVARTIS PHARMACEUTICALS · Healthcare & Pharmaceuticals · CEO · Reported as NARASIMHAN, VASANT K / NARASIMHAN, VASANT K. · 2 transaction rows
Other contributionsDerived from contributionsReported name + ZIP cluster; not a verified identity merge · EAST HANOVER, NJ, 07936 · US NOVARTIS PHARMACEUTICALS · Healthcare & Pharmaceuticals · VP NPS ASCVD & HEART FAILURE · 37 transaction rows
Other contributionsDerived from contributionsWhere the contributions went · 10 per page
Showing 1–10 of 12 · largest absolute amount first
PAC (qualified) · WASHINGTON, DC · 2,533 transaction rows
Other contributionsDerived from contributionsPAC (qualified) · WASHINGTON, DC · 1 transaction rows
49% Democratic / 49% Republican · 1% unclassifiedDerived from contributionsSuper PAC · HUDSON, WI · 12 transaction rows
RepublicanDerived from contributionsParty committee (qualified) · WASHINGTON, DC · 2 transaction rows
RepublicanDerived from contributionsHouse campaign committee · TARRYTOWN, NY · DAVIDSON, BETH · U.S. House NY 17 · 1 transaction rows
DemocraticDerived from contributionsHouse campaign committee · WILMINGTON, DE · MCBRIDE, SARAH ELIZABETH · U.S. House DE 00 · 2 transaction rows
DemocraticDerived from contributionsPAC with non-contribution account · NORTHAMPTON, MA · 2 transaction rows
20% Democratic · 80% unclassifiedDerived from contributionsHouse campaign committee · HOUSTON, TX · MENEFEE, CHRISTIAN · U.S. House TX 18 · 1 transaction rows
DemocraticDerived from contributionsPAC with non-contribution account · WASHINGTON, DC · 1 transaction rows
Party not classifiedUnclassifiedPAC (not qualified) · ARLINGTON, VA · 4 transaction rows
RepublicanDerived from contributionsIndividual transactions · 10 per page
Dates below are the FEC-reported contribution dates, not filing or import dates. These are individual contributions grouped by the reported employer field, not contributions by a company.
Largest contribution amounts first. Select Date of contribution or Amount to reverse the order.
Refunds remain negative. Memo-only rows are marked and are not additional money. Rows come from the latest available contribution publication.
Open full contribution table →Reported as US NOVARTIS PHARMACEUTICALS
Industry classification summary
The reported name is a direct match for Novartis Pharmaceuticals Corporation, the US subsidiary of the global pharmaceutical company Novartis AG. The industry classification is confirmed by research describing its focus on the development and commercialization of innovative medicines.
AI-generated classification based on saved sources
View source